Measurement of activated clotting time and whole blood heparin concentration during cardiopulmonary bypass

被引：0
|
作者：
Takashi Watanabe
Kazuaki Shirota
机构：
[1] Nagoya University School of Medicine,Department of Thoracic Surgery
来源：
The Japanese Journal of Thoracic and Cardiovascular Surgery | 1998年 / 46卷 / 6期
关键词：
Heparin; Cardiopulmonary Bypass; Activate Clotting Time; Heparin Dose; Heparin Concentration;
D O I：
10.1007/BF03250593
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：530 / 530
相关论文
共 50 条
  • [21] Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia
    Devignes, J
    de Maistre, E
    Grosjean, S
    Walter, AF
    Hacquard, M
    Mulot, A
    Longrois, D
    Carteaux, JP
    Lecompte, T
    ANNALES DE BIOLOGIE CLINIQUE, 2005, 63 (02) : 201 - 208
  • [22] A whole-blood analyzer (TAS) superior to activated clotting time (ACT) in monitoring heparin during and after coronary bypass surgery
    Joorgensen, B
    Bulow, R
    Toolbooll, P
    Stoffersen, E
    THROMBOSIS AND HAEMOSTASIS, 1997, : P3123 - P3123
  • [23] Measurement of whole blood factor Xa-activated clotting time during hemodialysis with low-molecular-weight heparin
    Mori M.
    Yoshitake S.
    Kitano T.
    Oda S.
    Noguchi T.
    Journal of Anesthesia, 1998, 12 (3) : 130 - 132
  • [24] Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass
    Mochizuki, T
    Olson, PJ
    Szlam, F
    Ramsay, JG
    Levy, JH
    ANESTHESIA AND ANALGESIA, 1998, 87 (04): : 781 - 785
  • [25] Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration
    Pappalardo, Federico
    Franco, Annalisa
    Crescenzi, Giuseppe
    De Simone, Francesco
    Torracca, Lucia
    Zangrillo, Alberto
    PERFUSION-UK, 2006, 21 (05): : 285 - 290
  • [26] Rapid biochemical measurement of heparin in whole blood during open heart surgery and cardiopulmonary bypass.
    Mielke, CH
    Oliver, SA
    Striepeke, S
    Granger, JL
    Brandley, B
    BLOOD, 1999, 94 (10) : 110B - 110B
  • [27] CONTROL OF HEPARINIZATION DURING CARDIOPULMONARY BYPASS - EXPERIENCE WITH THE ACTIVATED CLOTTING TIME METHOD
    KAMATH, BSK
    FOZARD, JR
    ANAESTHESIA, 1980, 35 (03) : 250 - 256
  • [28] Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass - Assessment of the whole blood ecarin clotting time
    Potzsch, B
    Madlener, K
    Seelig, C
    Riess, CF
    Greinacher, A
    MullerBerghaus, G
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (05) : 920 - 925
  • [29] Measurement of the activated clotting time during cardiopulmonary bypass:: differences between Hemotec® ACT and Hemochron® Jr apparatus
    Svenmarker, S
    Appelblad, M
    Jansson, E
    Häggmark, S
    PERFUSION-UK, 2004, 19 (05): : 289 - 294
  • [30] Factors associated with activated clotting time following heparin administration in pediatric cardiopulmonary bypass: A retrospective study
    Hida, Mizuho
    Kashiwa, Koichi
    Kurosawa, Hideo
    Takahashi, Mai
    Fujiya, Saori
    Fujishiro, Kazuki
    Shimoda, Junpei
    Kubo, Hitoshi
    Inokuchi, Ryota
    Doi, Kent
    Hirata, Yasutaka
    PERFUSION-UK, 2025,
12345